This is one of the biggest peptide regulatory shifts in years. And it's just getting started. The FDA has taken its first step toward reversing its 2023 stance, removing 12 peptides from US FDA to convene expert panel to review wider access to some peptides Reuters BREAKING: FDA UPDATES CATEGORY 2 BULKS LIST OFFICIALLY REMOVES PEPTIDES LIKE BPC 157 The first opportunity for reclassification comes on July 23 24 during the FDA's PCAC meeting Until then, peptides are FDA Peptide Category Update: Clarifying Misinformation Cole Thomas posted on the topic LinkedIn BPC 157: The peptide with big claims and scant evidence STAT